Related Experiment Video
Updated: Aug 2, 2025

In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions
Published on: October 21, 2022
Circular RNA ciRS-7 affects the propagation of Cryptosporidium parvum in HCT-8 cells via regulating miR-135a-5p/stat1
Yan-Ling Yin1, Xin Yang2, Shuang Huang2
1Key Laboratory of Ruminant Disease Prevention and Control (West), College of Veterinary Medicine, Northwest A&F University, Yangling 712100, China; Chongqing Three Gorges Vocational College, Chongqing 404155, China.
Abstract:
Cryptosporidium spp. are protozoan parasites that mainly inhabit intestinal epithelial cells, causing diarrheal diseases in humans and a great number of animals. Cryptosporidium parvum is the most common zoonotic species, responsible for nearly 45% of human cryptosporidiosis worldwide. Understanding the interaction mechanisms between C. parvum and host gastrointestinal epithelial cells has significant implications to control cryptosporidiosis. One up-regulated circRNA ciRS-7 was found previously by our group to promote in vitro propagation of C. parvum in HCT-8 cells. In the present study, miR-135a-5p, was found to be a miRNA target of ciRS-7. Cryptosporidium parvum infection induced significantly down-regulation of miR-135a-5p and dramatic up-regulation of its potential target stat1 gene at mRNA and protein levels. Dual luciferase reporter assays validated the physical interactions between miR-135a-5p and stat1, and between ciRS-7 and miR-135a-5p. Further study revealed that ciRS-7 could sponge miR-135a-5p to positively regulate the protein levels of STAT1 and phosphorylated STAT1 (p-STAT1) and thus promote C. parvum propagation in HCT-8 cells. Our findings further reveal the mystery of regulatory roles of host circRNAs during Cryptosporidium infection, and provide a novel insight to develop strategies to control cryptosporidiosis.
Insights
Host circular RNA ciRS-7 sponges miR-135a-5p, increasing STAT1 levels and promoting Cryptosporidium parvum infection in intestinal cells. This reveals new strategies for controlling cryptosporidiosis.
Area of Science:
- Molecular Biology
- Parasitology
- Host-Pathogen Interactions
Background:
- Cryptosporidium parvum causes widespread diarrheal disease (cryptosporidiosis) by infecting intestinal epithelial cells.
- Understanding host-pathogen interactions is crucial for developing control strategies against C. parvum.
- Previous research identified up-regulated circRNA ciRS-7 promoting C. parvum in vitro.
Purpose of the Study:
- To elucidate the regulatory role of ciRS-7 and its interaction with microRNAs in C. parvum infection.
- To investigate the molecular mechanisms by which ciRS-7 influences host cells during C. parvum infection.
Main Methods:
- Identified miR-135a-5p as a target of ciRS-7.
- Assessed changes in miR-135a-5p and STAT1 expression (mRNA and protein) post-C. parvum infection.
- Utilized dual luciferase reporter assays to confirm interactions between ciRS-7, miR-135a-5p, and STAT1.
Main Results:
- C. parvum infection down-regulated miR-135a-5p and up-regulated STAT1.
- ciRS-7 directly interacts with miR-135a-5p, and miR-135a-5p targets STAT1.
- ciRS-7 sponges miR-135a-5p, leading to increased STAT1 and phosphorylated STAT1 (p-STAT1), thereby promoting C. parvum propagation.
Conclusions:
- Host circRNA ciRS-7 regulates C. parvum infection by sponging miR-135a-5p and up-regulating the STAT1 pathway.
- This study reveals a novel regulatory mechanism involving host circRNAs in Cryptosporidium infection.
- Findings offer new insights for developing therapeutic strategies against cryptosporidiosis.
Related Concept Videos
Microtubules in Signaling
MicroRNAs
Experimental RNAi
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

